Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Cancer Vaccines Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increase in number of cancer patients along with growing geriatric population
5.1.1.2. Surge in patient awareness towards cancer therapy
5.1.1.3. Increase in prevalence of human papilloma virus (HPV) infections
5.1.2. Restraints
5.1.2.1. High cost for developing cancer vaccines
5.1.3. Opportunities
5.1.3.1. Increase in investments and government funding in development of cancer vaccines
5.1.3.2. Technological developments in cancer vaccines
5.1.4. Challenges
5.1.4.1. Longer time span required for manufacturing a single vaccine
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Cancer Vaccines Market, by Technology
6.1. Introduction
6.2. Antigen
6.3. Dendritic Cells
6.4. Recombinant Cancer Vaccines
6.5. Viral Vector & DNA Cancer Vaccines
6.6. Whole-cell Cancer Vaccines

7. Cancer Vaccines Market, by Treatment Method
7.1. Introduction
7.2. Preventive Vaccine
7.3. Therapeutic Vaccine

8. Cancer Vaccines Market, by Application
8.1. Introduction
8.2. Cervical Cancer
8.3. Prostate Cancer

9. Americas Cancer Vaccines Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Cancer Vaccines Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Cancer Vaccines Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Advaxis Inc.
13.1.2. Amgen Inc.
13.1.3. AstraZeneca PLC
13.1.4. Bayer AG
13.1.5. Celldex Therapeutics
13.1.6. Dynavax Technologies
13.1.7. GSK PLC
13.1.8. Helsinn Healthcare SA
13.1.9. Johnson & Johnson
13.1.10. Merck & Co., Inc.
13.1.11. Novartis International AG
13.1.12. Pfizer Inc.
13.1.13. Sanofi SA
13.1.14. Sanpower Group Co., Ltd.
13.1.15. Sun Pharmaceutical Industries Ltd.
13.2. Key Product Portfolio

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing



List of Figures

FIGURE 1. CANCER VACCINES MARKET RESEARCH PROCESS
FIGURE 2. CANCER VACCINES MARKET SIZE, 2023 VS 2030
FIGURE 3. CANCER VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. CANCER VACCINES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. CANCER VACCINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CANCER VACCINES MARKET DYNAMICS
FIGURE 7. CANCER VACCINES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 8. CANCER VACCINES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. CANCER VACCINES MARKET SIZE, BY TREATMENT METHOD, 2023 VS 2030 (%)
FIGURE 10. CANCER VACCINES MARKET SIZE, BY TREATMENT METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. CANCER VACCINES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. CANCER VACCINES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS CANCER VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS CANCER VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES CANCER VACCINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES CANCER VACCINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC CANCER VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC CANCER VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CANCER VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CANCER VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. CANCER VACCINES MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. CANCER VACCINES MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. CANCER VACCINES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
TABLE 3. CANCER VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CANCER VACCINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. CANCER VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 6. CANCER VACCINES MARKET SIZE, BY ANTIGEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. CANCER VACCINES MARKET SIZE, BY DENDRITIC CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. CANCER VACCINES MARKET SIZE, BY RECOMBINANT CANCER VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. CANCER VACCINES MARKET SIZE, BY VIRAL VECTOR & DNA CANCER VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. CANCER VACCINES MARKET SIZE, BY WHOLE-CELL CANCER VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. CANCER VACCINES MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 12. CANCER VACCINES MARKET SIZE, BY PREVENTIVE VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. CANCER VACCINES MARKET SIZE, BY THERAPEUTIC VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. CANCER VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 15. CANCER VACCINES MARKET SIZE, BY CERVICAL CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. CANCER VACCINES MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS CANCER VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS CANCER VACCINES MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS CANCER VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS CANCER VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 21. ARGENTINA CANCER VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA CANCER VACCINES MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA CANCER VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 24. BRAZIL CANCER VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 25. BRAZIL CANCER VACCINES MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL CANCER VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. CANADA CANCER VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 28. CANADA CANCER VACCINES MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 29. CANADA CANCER VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 30. MEXICO CANCER VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 31. MEXICO CANCER VACCINES MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 32. MEXICO CANCER VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES CANCER VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES CANCER VACCINES MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES CANCER VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES CANCER VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 37. ASIA-PACIFIC CANCER VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC CANCER VACCINES MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC CANCER VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC CANCER VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 41. AUSTRALIA CANCER VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 42. AUSTRALIA CANCER VACCINES MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA CANCER VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. CHINA CANCER VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 45. CHINA CANCER VACCINES MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 46. CHINA CANCER VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. INDIA CANCER VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 48. INDIA CANCER VACCINES MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 49. INDIA CANCER VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. INDONESIA CANCER VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 51. INDONESIA CANCER VACCINES MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA CANCER VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. JAPAN CANCER VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 54. JAPAN CANCER VACCINES MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 55. JAPAN CANCER VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. MALAYSIA CANCER VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 57. MALAYSIA CANCER VACCINES MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA CANCER VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. PHILIPPINES CANCER VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 60. PHILIPPINES CANCER VACCINES MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES CANCER VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. SINGAPORE CANCER VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 63. SINGAPORE CANCER VACCINES MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE CANCER VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. SOUTH KOREA CANCER VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 66. SOUTH KOREA CANCER VACCINES MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA CANCER VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. TAIWAN CANCER VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 69. TAIWAN CANCER VACCINES MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN CANCER VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. THAILAND CANCER VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 72. THAILAND CANCER VACCINES MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 73. THAILAND CANCER VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. VIETNAM CANCER VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 75. VIETNAM CANCER VACCINES MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM CANCER VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA CANCER VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA CANCER VACCINES MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA CANCER VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA CANCER VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 81. DENMARK CANCER VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 82. DENMARK CANCER VACCINES MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 83. DENMARK CANCER VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. EGYPT CANCER VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 85. EGYPT CANCER VACCINES MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 86. EGYPT CANCER VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. FINLAND CANCER VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 88. FINLAND CANCER VACCINES MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 89. FINLAND CANCER VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. FRANCE CANCER VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 91. FRANCE CANCER VACCINES MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 92. FRANCE CANCER VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. GERMANY CANCER VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 94. GERMANY CANCER VACCINES MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 95. GERMANY CANCER VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. ISRAEL CANCER VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 97. ISRAEL CANCER VACCINES MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL CANCER VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. ITALY CANCER VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 100. ITALY CANCER VACCINES MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 101. ITALY CANCER VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. NETHERLANDS CANCER VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 103. NETHERLANDS CANCER VACCINES MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS CANCER VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. NIGERIA CANCER VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 106. NIGERIA CANCER VACCINES MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA CANCER VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. NORWAY CANCER VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 109. NORWAY CANCER VACCINES MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 110. NORWAY CANCER VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. POLAND CANCER VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 112. POLAND CANCER VACCINES MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 113. POLAND CANCER VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. QATAR CANCER VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 115. QATAR CANCER VACCINES MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 116. QATAR CANCER VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA CANCER VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA CANCER VACCINES MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA CANCER VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. SAUDI ARABIA CANCER VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA CANCER VACCINES MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA CANCER VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. SOUTH AFRICA CANCER VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA CANCER VACCINES MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA CANCER VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. SPAIN CANCER VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 127. SPAIN CANCER VACCINES MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 128. SPAIN CANCER VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. SWEDEN CANCER VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN CANCER VACCINES MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN CANCER VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. SWITZERLAND CANCER VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 133. SWITZERLAND CANCER VACCINES MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND CANCER VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. TURKEY CANCER VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 136. TURKEY CANCER VACCINES MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 137. TURKEY CANCER VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. UNITED ARAB EMIRATES CANCER VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES CANCER VACCINES MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES CANCER VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM CANCER VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM CANCER VACCINES MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM CANCER VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. CANCER VACCINES MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 145. CANCER VACCINES MARKET SHARE, BY KEY PLAYER, 2023
TABLE 146. CANCER VACCINES MARKET LICENSE & PRICING